Skip to main content

Table 2 Assessment of Pre and Post ABMDO Transplantation

From: The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD)

Parameter

Pre operative

Post operative (Weeks)

P Value between pre operative and at 104 weeks

2

16

104

VAS

7.79 ± 1.06

4.07 ± 1.08

3.38 ± 0.72

2.38 ± 0.55

P = 0.001

MHHS

41.77 ± 5.37

49.9 ± 4.92

73.19 ± 6.48

84.8 ± 5.22

P = 0.001

ASS

2.76 ± 0.49

4.85 ± 0.87

6.2 ± 0.59

7.92 ± 0.90

P = 0.001

  1. VAS Visual Analogue Scale, MHHS  Modified Harris Hip Score, ASS  Azam-Sadat Score